Comparison of Zotarolimus-Eluting Stent vs Sirolimus-Eluting Stent for Diabetic Patients

Exclusion Criteria

• •History of bleeding diathesis or coagulopathy
• •Pregnant state
• •Known hypersensitivity or contra-indication to contrast agent and heparin
• •Limited life-expectancy (less than 1 year)
• •Acute ST elevation myocardial infarction on admission
• •Characteristics of lesion Left main disease In-stent restenosis Graft vessels
• •Hematological disease (Neutropenia \<3000/mm3, Thrombocytopenia \<100,000/mm3)
• •Hepatic dysfunction, liver enzyme (ALT and AST) elevation ≥ 3 times normal
• •Renal dysfunction, creatinine ≥ 2.0mg/dL
• •Contraindication to aspirin, clopidogrel or cilostazol
• •Left ventricular ejection fraction \<30%
• •Patients who are actively participating in another drug or device - investigational study, which have not completed the primary endpoint follow- up period.
• •Non-cardiac co-morbid conditions are present with life expectancy \<1 year or that may result in protocol non-compliance (per site investigator's medical judgment).